RIVN·Consumer Cyclical·EV & Mobility
Rivian R2 Deliveries Down 8.1% as R2 Rollout Faces Scrutiny
Can Rivian R2 Deliveries finally prove the EV maker can scale profitably, or is Wall Street still right to doubt…
EV & Mobility
RIVN·Consumer Cyclical·EV & Mobility
F·Consumer Cyclical·EV & Mobility
Ford Energy Strategy +5%: AI Power Story Lifts Ford
Can Ford Energy Strategy turn a legacy automaker into an AI infrastructure play before the market’s excitement runs ahead of…
XPEV·Consumer Cyclical·China ADRs
XPeng Earnings Q2 Outlook Targets 106K Deliveries After Q1 Miss
Can XPeng Earnings turn a weak quarter into a breakout story as deliveries are suddenly set to jump in Q2?
TSLA·Consumer Cyclical·EV & Mobility
Tesla SpaceX IPO +2.6%: Why the Listing Could Shake TSLA
Could a SpaceX listing unlock Musk’s empire value while pulling fresh momentum money away from Tesla at the same time?
NIO·Consumer Cyclical·China ADRs
NIO Earnings 112% Surge as Q1 Margins Rebound Strongly
Can NIO turn one strong quarter into a real comeback, or is China’s EV price war still the bigger story?
TSLA·Consumer Cyclical·EV & Mobility
Tesla FSD China Launch +3.3% Drives China Software Buzz
Can Tesla’s long-delayed FSD push in China finally prove that software, not just EV sales, deserves the market’s premium valuation?
TSLA·Consumer Cyclical·EV & Mobility
Tesla Earnings 42% Boom as FSD Expansion Lifts TSLA
Can Tesla Earnings keep supporting the stock if the real story is no longer cars, but software and autonomy?
RIVN·Consumer Cyclical·EV & Mobility
Rivian Insider Buying -3.4%: Director Bet Draws Attention
Why is Rivian Insider Buying suddenly standing out while the stock slides and most insider filings still look like routine…
TSLA·Consumer Cyclical·EV & Mobility
Tesla SpaceX IPO shock: TSLA -3.1% plunge and Musk risk
As the Tesla SpaceX IPO story heats up, is Elon Musk’s expanding empire finally stretching Tesla’s valuation and volatility too…
TSLA·Consumer Cyclical·EV & Mobility
Tesla Robotaxi -3.4%: New Autonomy Timeline Shocks Wall Street
Can the latest Tesla Robotaxi rollout promise really justify the stock’s rich valuation as competition and legal risks intensify?